Moderna announced Monday (Jan. 25) it will begin trials for booster shots that, when paired with the company’s FDA-authorized COVID-19 vaccine, could offer increased protection against variant strains of the virus that have emerged out of the United Kingdom and South Africa, coming as U.S. health officials and experts from the World Health Organization say they’re keeping a close eye on the mutations.